FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089727605> ?p ?o ?g. }

• W3089727605 endingPage "3006" @default.
• W3089727605 startingPage "2999" @default.
• W3089727605 abstract "OBJECTIVE Poor outcomes have been reported in patients with type 2 diabetes and coronavirus disease 2019 (COVID-19); thus, it is mandatory to explore novel therapeutic approaches for this population. RESEARCH DESIGN AND METHODS In a multicenter, case-control, retrospective, observational study, sitagliptin, an oral and highly selective dipeptidyl peptidase 4 inhibitor, was added to standard of care (e.g., insulin administration) at the time of hospitalization in patients with type 2 diabetes who were hospitalized with COVID-19. Every center also recruited at a 1:1 ratio untreated control subjects matched for age and sex. All patients had pneumonia and exhibited oxygen saturation &lt;95% when breathing ambient air or when receiving oxygen support. The primary end points were discharge from the hospital/death and improvement of clinical outcomes, defined as an increase in at least two points on a seven-category modified ordinal scale. Data were collected retrospectively from patients receiving sitagliptin from 1 March through 30 April 2020. RESULTS Of the 338 consecutive patients with type 2 diabetes and COVID-19 admitted in Northern Italy hospitals included in this study, 169 were on sitagliptin, while 169 were on standard of care. Treatment with sitagliptin at the time of hospitalization was associated with reduced mortality (18% vs. 37% of deceased patients; hazard ratio 0.44 [95% CI 0.29–0.66]; P = 0.0001), with an improvement in clinical outcomes (60% vs. 38% of improved patients; P = 0.0001) and with a greater number of hospital discharges (120 vs. 89 of discharged patients; P = 0.0008) compared with patients receiving standard of care, respectively. CONCLUSIONS In this multicenter, case-control, retrospective, observational study of patients with type 2 diabetes admitted to the hospital for COVID-19, sitagliptin treatment at the time of hospitalization was associated with reduced mortality and improved clinical outcomes as compared with standard-of-care treatment. The effects of sitagliptin in patients with type 2 diabetes and COVID-19 should be confirmed in an ongoing randomized, placebo-controlled trial." @default.
• W3089727605 created "2020-10-08" @default.
• W3089727605 creator A5000717557 @default.
• W3089727605 creator A5007460472 @default.
• W3089727605 creator A5010351936 @default.
• W3089727605 creator A5013378550 @default.
• W3089727605 creator A5015681797 @default.
• W3089727605 creator A5022917303 @default.
• W3089727605 creator A5023494315 @default.
• W3089727605 creator A5026873442 @default.
• W3089727605 creator A5028314110 @default.
• W3089727605 creator A5031371239 @default.
• W3089727605 creator A5033573686 @default.
• W3089727605 creator A5036532466 @default.
• W3089727605 creator A5040013682 @default.
• W3089727605 creator A5043029923 @default.
• W3089727605 creator A5046822593 @default.
• W3089727605 creator A5048121380 @default.
• W3089727605 creator A5053802958 @default.
• W3089727605 creator A5054756814 @default.
• W3089727605 creator A5056162271 @default.
• W3089727605 creator A5068011395 @default.
• W3089727605 creator A5070031573 @default.
• W3089727605 creator A5074382189 @default.
• W3089727605 creator A5075811484 @default.
• W3089727605 creator A5088008401 @default.
• W3089727605 creator A5088130294 @default.
• W3089727605 creator A5089781525 @default.
• W3089727605 creator A5090018866 @default.
• W3089727605 creator A5091360984 @default.
• W3089727605 creator A5091535937 @default.
• W3089727605 date "2020-09-29" @default.
• W3089727605 modified "2023-10-16" @default.
• W3089727605 title "Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study" @default.
• W3089727605 cites W1018980170 @default.
• W3089727605 cites W1978953702 @default.
• W3089727605 cites W1994743271 @default.
• W3089727605 cites W2054185381 @default.
• W3089727605 cites W2067336260 @default.
• W3089727605 cites W20782350 @default.
• W3089727605 cites W2083473802 @default.
• W3089727605 cites W2114531479 @default.
• W3089727605 cites W2119111857 @default.
• W3089727605 cites W2143413851 @default.
• W3089727605 cites W2171857834 @default.
• W3089727605 cites W2180946184 @default.
• W3089727605 cites W2363557399 @default.
• W3089727605 cites W2507543752 @default.
• W3089727605 cites W2570373354 @default.
• W3089727605 cites W2903300529 @default.
• W3089727605 cites W2905051451 @default.
• W3089727605 cites W2914024845 @default.
• W3089727605 cites W2916201199 @default.
• W3089727605 cites W2939798759 @default.
• W3089727605 cites W2969337822 @default.
• W3089727605 cites W3004280078 @default.
• W3089727605 cites W3008827533 @default.
• W3089727605 cites W3010441732 @default.
• W3089727605 cites W3011242477 @default.
• W3089727605 cites W3011994656 @default.
• W3089727605 cites W3012088820 @default.
• W3089727605 cites W3012379316 @default.
• W3089727605 cites W3013365852 @default.
• W3089727605 cites W3013985628 @default.
• W3089727605 cites W3015989800 @default.
• W3089727605 cites W3016311875 @default.
• W3089727605 cites W3017667605 @default.
• W3089727605 cites W3017756122 @default.
• W3089727605 cites W3017792525 @default.
• W3089727605 cites W3018002427 @default.
• W3089727605 cites W3021684016 @default.
• W3089727605 cites W3023437671 @default.
• W3089727605 cites W3024432354 @default.
• W3089727605 cites W3034081489 @default.
• W3089727605 cites W3038505425 @default.
• W3089727605 cites W3042607231 @default.
• W3089727605 cites W3042710560 @default.
• W3089727605 cites W4235377734 @default.
• W3089727605 cites W44929223 @default.
• W3089727605 doi "https://doi.org/10.2337/dc20-1521" @default.
• W3089727605 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7770266" @default.
• W3089727605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32994187" @default.
• W3089727605 hasPublicationYear "2020" @default.
• W3089727605 type Work @default.
• W3089727605 sameAs 3089727605 @default.
• W3089727605 citedByCount "187" @default.
• W3089727605 countsByYear W30897276052020 @default.
• W3089727605 countsByYear W30897276052021 @default.
• W3089727605 countsByYear W30897276052022 @default.
• W3089727605 countsByYear W30897276052023 @default.
• W3089727605 crossrefType "journal-article" @default.
• W3089727605 hasAuthorship W3089727605A5000717557 @default.
• W3089727605 hasAuthorship W3089727605A5007460472 @default.
• W3089727605 hasAuthorship W3089727605A5010351936 @default.
• W3089727605 hasAuthorship W3089727605A5013378550 @default.
• W3089727605 hasAuthorship W3089727605A5015681797 @default.
• W3089727605 hasAuthorship W3089727605A5022917303 @default.
• W3089727605 hasAuthorship W3089727605A5023494315 @default.

• next